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Abstract. 
 
High mobility group 1 (HMG1) protein is an 
abundant and conserved component of vertebrate nu-
clei and has been proposed to play a structural role in 
chromatin organization, possibly similar to that of his-
tone H1. However, a high abundance of HMG1 had 
also been reported in the cytoplasm and on the surface 
of mammalian cells. We conclusively show that HMG1 
is a nuclear protein, since several different anti-HMG1 
antibodies stain the nucleoplasm of cultured cells, and 
epitope-tagged HMG1 is localized in the nucleus only. 
The protein is excluded from nucleoli and is not associ-
ated to specific nuclear structures but rather appears to 
be uniformly distributed. HMG1 can bind in vitro to re-
constituted core nucleosomes but is not stably associ-
ated to chromatin in live cells. At metaphase, HMG1 is 
detached from condensed chromosomes, contrary to 
histone H1. During interphase, HMG1 readily diffuses 
out of nuclei after permeabilization of the nuclear 
membranes with detergents, whereas histone H1 re-
mains associated to chromatin. These properties ex-
clude a shared function for HMG1 and H1 in differenti-
ated cells, in spite of their similar biochemical 
properties. HMG1 may be stably associated only to a 
very minor population of nucleosomes or may interact 
transiently with nucleosomes during dynamic processes 
of chromatin remodeling.
 
H
 
igh
 
 mobility group 1 protein (HMG1)
 
1
 
 is a very
abundant and highly conserved component of
chromatin which is present in all mammalian tis-
sues and cells. Moreover, HMG1-like proteins also exist in
yeast, protozoa, and plants (for reviews see Bustin et al.,
1990 and Bianchi, 1995).
HMG1 contains two DNA-binding domains of the HMG
box class: they bind with low affinity to single-stranded,
linear duplex and supercoiled DNA (Sheflin and Spauld-
ing, 1989; Stros et al., 1994) and with high affinity and
specificity to DNA containing sharp bends or kinks, such
as four-way junctions or DNA covalently modified with
the antitumor drug cisplatin (Bianchi et al., 1989, 1992; Pil
and Lippard, 1992). More generally, HMG1 has the ability
to transiently introduce bends or kinks into linear DNA
and therefore is functionally (but not structurally) similar
to the prokaryotic proteins HU and IHF, which it can sub-
stitute in several in vitro reactions (for review see Bianchi,
1994).
The evolutionary conservation of HMG1 suggests that it
serves an indispensable function. Roles have been sug-
gested in DNA replication, chromatin assembly and disas-
sembly (Bonne-Andrea et al., 1984; Waga et al., 1990;
Travers et al., 1994), and transcription (Tremethick and
Molloy, 1988; Singh and Dixon, 1990; Ge and Roeder,
1994; Stelzer et al., 1994; Shykind et al., 1995); however,
none of these hypotheses has been confirmed unequivo-
cally. More recently it has been proposed that HMG1
plays a role similar to that of histone H1 in the organiza-
tion and/or maintenance of chromatin. Both HMG1 and
histone H1 bind to bent DNA structures (Bianchi et al.,
1989; Varga-Weisz et al., 1993), and both appear to inter-
act with linker DNA sequences (Schröter and Bode, 1982;
van Holde, 1988). Moreover, 
 
Xenopus
 
 HMG1 binds to nu-
cleosomes in vitro in much the same way as histone H1
and appears to replace histone H1 during early embryo-
genesis (Dimitrov et al., 1993, 1994; Nightingale et al.,
1996). Likewise, HMG-D, a 
 
Drosophila
 
 homolog of
HMG1, associates with condensed chromatin during em-
bryonal development and is gradually replaced by histone
H1 after the midblastula transition (Ner and Travers,
1994).
The present study focuses on the subcellular localization
of mammalian HMG1 and its association with chromo-
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somes and chromatin during interphase and metaphase.
We show with different antibodies that in nondividing fi-
broblasts HMG1 is localized exclusively within the nu-
cleus. During metaphase, HMG1, like many transcription
factors, detaches from condensed chromosomes and dif-
fuses to the cytoplasm. Histone H1, on the other hand, re-
mains bound to mitotic chromosomes. Moreover, HMG1
is released from interphase nuclei if the membranes are
permeabilized with detergents. Thus, the association of
mammalian HMG1 with chromatin is much less stable
than that of linker histone H1. We suggest that histone H1
prevents HMG1 from binding to nucleosomes and that
HMG1 can have a role as a bulk structural protein of chro-
matin only when histone H1 is absent.
 
Materials and Methods
 
Preparation of Antibodies against HMG1
 
HMG1/M1-K89 and HMG1/M1-F147 were expressed and purified in 
 
Es-
cherichia coli
 
 as previously described (Falciola et al., 1994). Antibody
mAP-bA was raised by injecting BALB/c mice four times with 200 
 
m
 
g of
HMG1/M1-F89 at 2 wk intervals. Chicken antibodies were raised by in-
jecting 200 
 
m
 
g of HMG1/M1-F147 three times at 2 wk intervals. Antibod-
ies mAP-bA and chIP-AB were affinity purified on the cognate native an-
tigen immobilized on CL-4B Sepharose (Pharmacia Biotech, Piscataway,
NJ) at the concentration of 1 mg/ml and eluted with 0.1 M glycine-HCl
(pH 2.5). Antibody chWB-AB was affinity purified using a strip of Immo-
bilon filter (Millipore Corp., Bedford, MA) bearing 2 mg of HMG1/M1-
F147 transferred from an SDS-PAGE gel.
 
Other Antibodies
 
The mouse monoclonal IgM HBC-7, which specifically recognizes the
NH
 
2
 
-terminal region of histone H2B (Whitfield et al., 1986), was a gift
from B.M. Turner (University of Birmingham, UK). The chicken anti-
recAtn antibody was kindly provided by H. Rauvala (Biotekniiken Insti-
tuutti, Helsinki, Finland), the rabbit anti–rat H1 antibody by M. Bustin
(National Cancer Institute, Bethesda, MD), and the rabbit anti-HMGI(Y)
antiserum by D. Thanos (Columbia University, New York, NY). The bio-
tinylated anti-HA mouse mAb 12CA5, recognizing the nonapeptide
YPYDVPDYA, was purchased from Boehringer Mannheim Corp. (Mann-
heim, Germany).
 
Dot Blots, Immunoprecipitations, and Western Blots
 
For dot blots, purified proteins were spotted onto wet Immobilon filters
(Millipore Corp.). For Western blots, samples were applied to 10% tri-
cine–SDS–polyacrylamide gels (Schägger and von Jagow, 1987) and then
electroblotted onto Immobilon filters. Filters were blocked by incubation
for 1 h in TBST (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, and 0.1% Triton
X-100) containing 10% skim milk and probed with antibodies diluted in
TBST containing 0.1% BSA.
For immunoprecipitations, 400 ng of purified proteins dissolved in 200 
 
m
 
l
of IP buffer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% NP-40, 1 mM
EDTA, 1% BSA, 1 mM DTT, and 0.2 mM PMSF) were mixed with 25 
 
m
 
l
chIP-AB and 20 
 
m
 
l (packed volume) of swollen protein A-Sepharose
(Pharmacia Biotech) presaturated with rabbit anti–chicken Ig (Zymed
Labs, Inc., S. San Francisco, CA). The suspension was incubated for 1 h at
room temperature with mild agitation. The beads were centrifuged at 800
rpm in a refrigerated Eppendorf microfuge and washed three times with
ice-cold IP buffer. The bound protein was eluted using 50 
 
m
 
l of SDS-
PAGE loading buffer and analyzed by Western blotting.
For detection of chWB-AB, we used a rabbit anti–chicken IgY second-
ary antibody conjugated to alkaline phosphatase (Chemicon Intl., Inc.,
Temecula, CA), which was revealed with either BCIP/NBT for color reac-
tions or CDP-Star (Boehringer Mannheim Corp.) for chemiluminescence.
The mouse 12CA5 monoclonal antibody was detected by donkey anti–
mouse Ig secondary antibody conjugated to HRP (Amersham Corp., Ar-
lington Heights, IL). For histone H1 and HMG-I(Y) detection, incubation
with the cognate rabbit primary antibodies was followed by incubation
with donkey anti–rabbit Ig conjugated with HRP (Amersham Corp.). For
lactate dehydrogenase (LDH) detection, the goat primary antibody was
followed by incubation with rabbit anti–goat Ig conjugated with HRP
(Southern Biotechnology, Birmingham, AL). HRP was revealed using a
Western blotting system (ECL; Amersham Corp.).
 
Immunofluorescence
 
All cell lines were cultured as monolayers on glass coverslips. Cells were
fixed in 4% paraformaldehyde in PBS for 10 min at room temperature.
After rinsing, the coverslips were stored in PBS containing 0.02% sodium
azide, no longer than 1 wk at 4
 
8
 
C before use. Different permeabilizing
agents were tested: 0.1% NP-40, 0.1% SDS, 0.1% Triton X-100 (all for 5
min at room temperature) and methanol for 5 min at 
 
2
 
20
 
8
 
C. Results were
always comparable. The coverslips were then incubated with blocking
solution (PBS containing 1% BSA and 0.05% Tween-20) followed by pri-
mary and secondary antibodies (FITC-conjugated goat anti–chicken Ig
antibodies; Southern Biotechnology; and FITC- or rhodamine-conjugated
goat anti–mouse Ig antibodies; Sigma Chemical Co., St. Louis, MO) and
finally mounted on glass slides with PBS containing 25% glycerol, 100 mg/
ml DABCO as antifading reagent, 0.02% sodium azide, and 100 
 
m
 
g/ml
Hoechst 33258. Every incubation was followed by three rinses in PBS con-
taining 0.05% Tween-20. Specimens were examined using an Olympus
BH-2 fluorescence microscope with the standard filters for FITC,
rhodamine, and Hoechst 33258 emission. Photomicrographs were taken
with Ektachrome 400 HC films (Kodak) and either printed directly or
scanned and processed using Adobe Photoshop software. Confocal laser
scanning microscopy was performed with a Zeiss laser fluorescence micro-
scope equipped with argon and helium lasers. Double fluorescence signals
were separated by a two-band filter. The emitted signal was digitalized by
Kallman filter collection, and each section was scanned eight times.
 
Plasmids
 
Plasmid p-mHMG1 consists of a 9-kb EcoRI–NsiI fragment containing
the entire mouse 
 
Hmg1
 
 gene, cloned in pBlueScript. To obtain plasmid
pmHMG1tag, the sequence 5
 
9
 
-TACCCATACGACGTCCCAGACTAC-
GCT-3
 
9
 
, coding for the nonapeptide YPYDVPDYA (HA epitope), was
inserted by mutagenic PCR into exon 2 of the 
 
Hmg1
 
 gene, between amino
acids 1 and 2. This insertion was the only modification to the genomic
fragment. The construct was completely sequenced to verify its identity.
All oligonucleotides were purchased from Genset (Paris, France). DNA
modification and restriction enzymes were from Boehringer Mannheim, Pro-
mega Biotech (Madison, WI), and New England Biolabs (Beverly, MA).
 
Nucleosome Electrophoresis Mobility Shift Assays
 
A 5
 
9
 
 labeled fragment, encompassing mouse rDNA sequences from 
 
2
 
160
to 
 
1
 
16, was generated by PCR and used for nucleosome assembly by salt
dialysis. 5 femtomoles of rDNA was incubated with 200 ng of carrier DNA
(phage 
 
l
 
 DNA cut with HaeIII) and 100 ng of purified chicken histones in
a final volume of 20 
 
m
 
l in a buffer containing 2 M NaCl, 10 mM Tris-HCl,
pH 7.6, 1 mM EDTA, 0.1% NP-40, 1 mM 
 
b
 
-mercaptoethanol. The prepa-
rations were dialyzed overnight against the same buffer containing 50 mM
NaCl. Nucleosomes were then incubated with 0–500 ng of HMG1 for 15
min at room temperature. The samples were analyzed by electrophoresis
on 0.7% agarose gels in 0.5
 
3
 
 TBE. Gels were dried on paper and autora-
diographed.
 
Cell Culture and Transfection
 
All cell lines were grown in DME supplemented with 10% newborn calf
serum (NCF; GIBCO BRL, Gaithersburg, MD). Transfections were per-
formed by the calcium phosphate method. NIH 3T3 clones stably trans-
formed with pmHMG1tag were obtained by transfecting 5 
 
3
 
 10
 
5
 
 cells with
20 
 
m
 
g of pmHMG1tag plasmid and 1 
 
m
 
g of pRSV-neo plasmid, followed
by selection with 900 
 
m
 
g/ml G418 for 11 d.
 
Sucrose Gradient Fractionation of Chromatin
 
About 50 million NIH 3T3 fibroblasts grown to near confluence were
washed with ice-cold RSB buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl,
3 mM MgCl
 
2
 
) and resuspended in 25 ml of RSB buffer. The cell suspen-
sion was then supplemented with 5 ml of RSB buffer containing 1.2 mM
PMSF and 6 
 
m
 
g each of leupeptin, pepstatin, and antipain, homogenized
on ice by 20 strokes in a glass teflon homogenizer, and centrifuged at 500 
 
g 
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for 5 min at 4
 
8
 
C. Nuclei were resuspended to a final absorbance of 3.8 at
260 nm in buffer M (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM CaCl
 
2
 
,
0.1% NP-40, and 6 
 
m
 
g each of leupeptin, pepstatin, and antipain) and di-
gested in 400 
 
m
 
l aliquots for 5 min at 37
 
8
 
C with varying amounts of micro-
coccal nuclease (MNase; Worthington Biochemical Corp., Freehold, NJ).
The results reported were obtained with 40 U/ml of MNase; different ex-
tents of digestion gave comparable results (not shown). The digestion was
stopped and nuclei were lysed by the addition of 1.6 ml of 1.5 mM EDTA.
The suspension was layered onto a 5–28% linear sucrose gradient (30 ml)
prepared in 10 mM Tris-HCl, pH 7.4, 10 mM NaCl, and protease inhibi-
tors as above. The gradients were centrifuged at 24,000 rpm for 30 h at 4
 
8
 
C
in a SW27 Beckman rotor. Fractions (1 ml) were analyzed for DNA con-
tent after phenol–chloroform extraction and for protein content after pre-
cipitation in 20% TCA.
 
Differential Permeabilization of Cells
 
NIH 3T3 fibroblasts were grown to subconfluence in 24-well plates (Fal-
con Plastics, Cockeysville, MD). Adherent cells were washed three times
with ice-cold transport buffer (TB buffer), containing 20 mM Hepes, pH
7.3, 110 mM K-acetate, 5 mM Na-acetate, 2 mM Mg-acetate, 1 mM
EGTA, 2 mM DTT, and pepstatin, antipain, and leupeptin at 1 
 
m
 
g/ml each
(Adam et al., 1990). They were then incubated for 5 min on ice in 80 
 
m
 
l of
TB buffer or TB buffer with 0.1% NP-40 or 40 
 
m
 
g/ml digitonin (Sigma
Chemical Co.). Supernatants were recovered, and cell remnants were
incubated for 10 min at 37
 
8
 
C with 80 
 
m
 
l of TB buffer plus 0.1% NP-40,
10 mM MnCl
 
2
 
, and 20 
 
m
 
g/ml DNaseI (Boehringer Mannheim Corp.).
SDS-PAGE loading buffer was then added to supernatants and cell rem-
nants, and samples were analyzed by Western blotting.
Mitotic and interphase cells were obtained and processed essentially as
described (Martinez-Balbás et al., 1995). NIH 3T3 fibroblasts, grown in
75-cm
 
2
 
 flasks (Costar, Cambridge, MA) to 
 
z
 
70% confluence, were ex-
posed to 50 ng/ml nocodazole (Janssen Chimica, Beerse, Belgium) for 16 h.
Cells blocked in mitosis were detached by manual shaking of the culture
flasks and recovered by centrifugation at 800 
 
g
 
. Interphase cells remained
attached to the flask bottom and were recovered by mild trypsinization
and centrifugation. Both cell populations were washed once in PBS, once
in ice-cold TB buffer, and finally resuspended in 0.5 ml of ice-cold TB
buffer. Small aliquots were stained with Hoechst 33258 and observed by
fluorescence microscopy: 
 
.
 
95% of the cells detached by shaking were
found to have condensed chromosomes, against 
 
,
 
2% of the cells that re-
sisted detachment. Mitotic and interphase cells were permeabilized by
adding one volume of ice-cold TB buffer containing 0.2% NP-40, 2 
 
m
 
g/ml
each of leupeptin, pepstatin, and antipain, and 0.4 mM PMSF. Cells were
then centrifuged for 3 min at 13,000 rpm in a refrigerated Eppendorf
microfuge (Brinkman Instruments, Westbury, NY). Supernatants were re-
covered, and the original volume was reconstituted with TB buffer con-
taining 0.1% NP-40, 10 mM MnCl
 
2
 
, and 20 
 
m
 
g/ml DNaseI. The sus-
pensions were incubated for 10 min at 37
 
8
 
C. SDS-PAGE loading buffer
was then added to supernatants and cell remnants, and samples were ana-
lyzed by Western blotting.
 
Results
 
Anti-HMG1 Antibodies Stain the Cell Nucleus
 
Several previous cell fractionation and immunofluores-
cence studies indicated that HMG1 is located both in the
cytoplasm and in the nucleus of mammalian cells (Bustin
and Neihart, 1979; Isackson et al., 1980; Einck et al., 1984;
Kuehl et al., 1984; Mosevitsky et al., 1989). Moreover, HMG1
has been localized to the surface of neural and fibroblas-
toid cells (Parkkinen et al., 1993). These results are not
necessarily in conflict with HMG1’s proposed role(s) as a
DNA-binding protein but warranted a reconsideration of
HMG1’s subcellular localization.
Because of the high evolutionary conservation of HMG1,
antibodies are hard to obtain, and even repeated injection
Figure 1. (A) Reactivity of
the various anti-HMG1 anti-
bodies used in this study. For
each antibody preparation
the species of origin is indi-
cated (m, mouse; ch,
chicken), and the ability (1)
or inability (2) to recognize
boxes A and B of HMG1 by
Western blotting (dena-
tured) or by immunoprecipi-
tation (native) is also shown.
The notation 6 indicates that
recovery of the HMG1bA
polypeptide by immunopre-
cipitation is ,5% under the
conditions indicated under
Materials and Methods. (B)
Reactivity of the chWB-AB
antibody in Western blots.
Whole NIH 3T3 cells were
lysed by addition of SDS-
PAGE loading buffer, and
10 mg of total protein was
loaded on a 10% tricine–SDS–
polyacrylamide gel (lane
3T3), alongside 20 ng of puri-
fied recombinant HMG1bA
polypeptide (lane bA) or 20 ng of purified recombinant HMG1bB polypeptide (lane bB). (C and D) Anti-HMG1 antibodies stain the
cell nucleus. NIH 3T3 cells were grown on glass coverslips, fixed with paraformaldehyde, permeabilized with 0.1% NP-40, and stained
with anti-recAtn (C) and Hoechst 33258 (D). (E and F) Localization of HMG1 by confocal microscopy. HeLa cells were fixed with
paraformaldehyde, permeabilized with 0.1% SDS, stained with mAP-bA antibody, and viewed in green fluorescence (E) or by phase
contrast microscopy (F). Bars, 10 mm. 
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of rabbits and mice with high doses of purified HMG1
yields sera with low antibody titers. For this study we have
raised antibodies to two different truncated forms of HMG1,
to avoid the production of antibodies reactive against the
COOH-terminal stretch of negatively charged amino acids.
Antibody mAP-bA was obtained by immunization of mice
with HMG1/M1-F89, a truncated protein encompassing
HMG1 box A. The second antibody was obtained by immu-
nizing a hen with HMG1/M1-K147, a polypeptide contain-
ing both boxes A and B of HMG1. The antibodies were pu-
rified from egg yolks by affinity chromatography using either
immobilized native HMG1/M1-K147 (chIP-AB) or dena-
tured HMG1/M1-K147 (chWB-AB). Finally, we used the
original anti-HMG1 chicken antibody (anti-recAtn) raised
against recombinant rat amphoterin, which is molecularly
identical to HMG1 (Parkkinen et al., 1993).
The four different antibody preparations have different
reactivities against HMG1, as shown in Fig. 1 
 
A
 
. Reactivity
against the native antigens was assessed by dot immuno-
blots or immunoprecipitation experiments (not shown);
reactivity against the denatured antigens was assessed with
Western blots (Fig. 1 
 
B
 
). In different cell lines (NIH 3T3
fibroblasts, HeLa and Jurkat cells, and mouse Schwann
cells) each of the antibodies stained the nucleus (Fig. 1,
 
C
 
–
 
F
 
 and results not shown). The result was the same with
several fixation regimes and permeabilization agents. Sig-
nificantly, the distribution of HMG1 and of AT-rich het-
erochromatin (revealed by Hoechst 33258 as spots of
brighter fluorescence) do not correlate (Fig. 1, compare 
 
C
 
with 
 
D
 
). Confocal microscopy (Fig. 1, 
 
E
 
 and 
 
F
 
) revealed a
 
diffuse, finely punctate pattern of staining, with little or no
HMG1 in the nucleoli.
 
Tagged HMG1 Protein Is Accumulated
in the Cell Nucleus
 
HMG1 is a member of a protein family including HMG2
and 
 
z
 
80 HMG1-related sequences (Ferrari et al., 1994).
Figure 2. The product of the
Hmg1 gene localizes to the nu-
cleus. NIH 3T3 fibroblasts sta-
bly transfected with the
pHMG1tag plasmid were fixed
and stained simultaneously
with (A) Hoechst 33258, (B)
anti-HMG1 antibody chIP-
AB, and (C) monoclonal anti-
body 12CA5 recognizing the
HA epitope. (D) Structure of
the Hmg1-tag gene. The mouse
gene  Hmg1, which codes for
protein HMG1, is transcribed
under the control of its own
strong promoter/enhancer. Ex-
ons are numbered. Black boxes
represent untranslated sequences
and white boxes translated se-
quences. Plasmid pmHMG1
was modified by the insertion
of 27 bp coding for the HA
epitope (bold and underlined)
immediately after the ATG
codon for the first methionine
of HMG1 and in frame with the
rest of the protein. A stable
clone (c47) expressing HMG1tag
approximately to the same
level of unmodified HMG1 was selected. (E) Western blotting of whole cell extracts from wild-type fibroblasts (lanes 3T3) and from the
stable transfected cells (lanes c47). The anti-HMG1 antibody chWB-AB (left) recognizes in the same way HMG1 and HMG1tag; the
monoclonal antibody 12CA5 recognizes the HA epitope (right). Protein HMG1tag runs slightly slower than wild-type HMG1 in tricine–
SDS-PAGE because of the addition of nine amino acids.
Figure 3. HMG1 binds to reconstituted mononucleosomes. A la-
beled DNA fragment (176 bp) was assembled into mononucleo-
somes, incubated with increasing amounts (0, 10, 50, 100, and 500
ng) of HMG1 (lanes 6–10), and electrophoresed on a 0.7% aga-
rose gel. DNA not assembled in nucleosomes was treated simi-
larly for comparison (lanes 1–5). The bands corresponding to free
DNA, to nucleosome particles, and to HMG1–nucleosome com-
plexes are indicated.Falciola et al. HMG1 Exclusion from Chromatin In Vivo 23
To exclude the possibility that our antibodies could cross
react with proteins closely related to HMG1, we modified
the cloned Hmg1 gene by adding a sequence coding for a
nonapeptide from influenza hemagglutinin. The modifica-
tion does not alter the exon–intron organization of the gene
nor its 59 untranscribed region (Fig. 2 D). We obtained
several NIH 3T3 clones stably transformed with the
tagged gene, one of which (c47) expressed similar amounts
of HMG1 and HMG1tag (Fig. 2 E). The anti-HA mAb
does not stain wild-type NIH 3T3 fibroblasts but brightly
stains the nucleus of transformed cells (Fig. 2 C).
HMG1 Protein Associates to Nucleosomes In Vitro
but Not in Condensed Chromosomes
Nightingale et al. (1996) have recently shown that Xeno-
pus HMG1 forms stable complexes with in vitro reconsti-
tuted nucleosomes, similar to the complexes formed by
histone H1 and its embryonic variant B4. Both HMG1 and
B4 associate with linker DNA and protect it from micro-
coccal nuclease digestion. We confirmed these observations
with mammalian HMG1: HMG1 binds very weakly to lin-
ear DNA not organized in nucleosomes, whereas it forms
complexes with in vitro reconstituted core mononucleo-
somes (Fig. 3). Nucleosomes lacking linker DNA were un-
able to bind HMG1 (results not shown).
To further confirm the association of HMG1 with nu-
cleosomes, we then probed whether HMG1 is an integral
component of condensed chromosomes, like its proposed
Drosophila homolog, HMG-D (Ner and Travers, 1994),
and histone H1 (Breneman et al., 1993). Unexpectedly, in
Figure 4. HMG1 protein is not associated to mitotic condensed chromosomes. Dividing NIH 3T3 fibroblasts were fixed and stained for
HMG1 with antibody chIP-AB (top row, green fluorescence) and for DNA with Hoechst 33258 (bottom row, blue fluorescence). Repre-
sentative cells at different stages during mitosis: prophase (A), metaphase (B), anaphase (C), and telophase (D). After the breakdown
of the nuclear membrane, HMG1 diffuses throughout the cytoplasm, and the pattern of green fluorescence corresponds to the shape of
the cell. However, fluorescence from HMG1 is clearly reduced in correspondence to the volume occupied by condensed chromosomes
(compare top and bottom images), indicating that HMG1 is not associated with DNA during mitosis. After cell division and the refor-
mation of nuclear membranes (D), the majority of HMG1 colocalizes with DNA, but some is still found in the cytoplasm, suggesting
that the protein is being concentrated in the nuclei by passage through the nuclear membrane.
Figure 5. Core histone H2B and linker histone H1 remain associ-
ated to condensed chromosomes throughout mitosis. As a control
for the mitotic displacement observed with HMG1, dividing NIH
3T3 fibroblasts were fixed and stained for DNA with Hoechst
33258 (bottom) and either (A) for histone H2B with the mono-
clonal IgM HBC-7 (top) or (B) for linker histones with a rabbit
polyclonal antibody against histone H1 (top).The Journal of Cell Biology, Volume 137, 1997 24
fibroblasts undergoing mitosis our anti-HMG1 antibodies
stained the cytoplasm in a diffuse way (Fig. 4 and results
not shown), while the chromosomes appear as dark areas,
indicating that HMG1 is displaced from condensed chro-
matin. As a control for the accessibility of mitotic chromo-
somes to antibodies, the same cells were stained with the
monoclonal IgM antibody HBC-7 directed against histone
H2B (Whitfield et al., 1986) and with a polyclonal rabbit
antibody directed against histone H1. In contrast to the
anti-HMG1 antibodies, the antibodies against core and
linker histones brightly stained the condensed chromo-
somes (Fig. 5).
HMG1 Is Weakly Associated with Nucleosomes in 
Interphase Chromosomes
The results shown above suggest that the bulk of HMG1 is
not associated with mitotic chromatin. To examine HMG1’s
association to chromatin during interphase, nuclei of NIH
3T3 fibroblasts were partially digested with micrococcal
nuclease, and nucleosomal particles were fractionated on
sucrose gradients (Fig. 6). Consistent with previous data,
histone H1 was found associated with mono- and polynu-
cleosomes. Most of HMG1, however, was recovered at the
top of the gradient in fractions that do not contain DNA;
only longer exposures of the Western blot revealed a mi-
nor amount of HMG1 in the fractions containing polynu-
cleosomes (Fig. 6, lanes 20–26).
Since our results are in contrast to the prevailing view
that HMG1 is a structural component of chromatin (van
Holde, 1988), we studied the interaction of HMG1 with in-
terphase chromatin by a more gentle technique. Monolay-
ers of fibroblasts were treated either with digitonin, which
permeabilizes the plasma membrane exclusively (Diaz and
Figure 6. A minor fraction of HMG1 cofractionates with polynu-
cleosomes in sucrose gradients. Nuclei of NIH 3T3 fibroblasts
were partially digested with micrococcal nuclease, lysed, and sed-
imented through a sucrose gradient (see Materials and Methods).
Individual fractions were analyzed by Western blotting for the
presence of HMG1 and histone H1; DNA was also extracted
from the fractions and analyzed on a 2% agarose gel.
Figure 7. HMG1 leaks out from detergent-permeabilized nuclei
of adherent cells, but histone H1 does not. Adherent NIH 3T3 fi-
broblasts were incubated in buffer with no detergent (lanes 3 and
4), in buffer containing 0.1% NP-40 (lanes 1 and 2), or in buffer
containing 40 mg/ml digitonin (lanes 5 and 6). After incubation,
the buffer bathing the cells (lanes 1, 3, and 5; S, supernatant) and
the remnants of permeabilized cells (lanes 2, 4, and 6; P, pellet)
were analyzed by Western blotting with antibodies against LDH,
HMG1, and histone H1. Digitonin selectively permeabilizes the
plasma membrane and causes the complete leakage of LDH but
not of HMG1 and H1. The faint bands in lanes 2 and 6 do not cor-
respond to LDH, because they have a slightly different molecular
weight. NP-40 causes the disruption of all membranes including
the nuclear ones: LDH is completely released, as well as z75%
of HMG1 (as determined by densitometric analysis), but H1 re-
mains associated with the DNA. We observed an incomplete re-
lease of HMG1 only when we permeabilized cells still attached to
their plastic substrate, possibly because HMG1 sticks avidly to se-
creted glycoproteins (Falciola, L., and M.E. Bianchi, unpublished
results). 
Stahl, 1989), or with NP-40, which permeabilizes all cellu-
lar membranes including the nuclear ones. The proteins
released in the medium and the cell remnants attached to
the plastic surface were analyzed by Western blotting us-
ing anti-HMG1 and anti-histone H1, as well as a control
antibody against LDH. As shown in Fig. 7 A, LDH was al-
most quantitatively released from the cells by treatment
with digitonin, while HMG1 and histone H1 remained con-
tained within the permeabilized cells. On the other hand,
treatment with NP-40 released the majority of HMG1,
whereas histone H1 remained associated to the cell rem-
nants. The release of HMG1, but not of histone H1, from
NP-40–treated cells was also revealed by immunofluores-
cence. Histone H1 remained within the nucleus in cells
fixed either before or after permeabilization, whereas
HMG1 was lost from cells permeabilized before fixation
(data not shown).
We also compared directly the detergent-mediated re-
lease of HMG1 from metaphase and interphase cells. NIH
3T3 fibroblasts were treated with nocodazole, an inhibitor
of microtubule assembly; mitotic cells were shaken off the
dishes, while nonmitotic cells were detached by mild tryp-
sin digestion (Martinez-Balbás et al., 1995). The two cell pop-
ulations were then permeabilized with NP-40 and ana-
lyzed for protein retention by Western blotting (Fig. 8). InFalciola et al. HMG1 Exclusion from Chromatin In Vivo 25
both mitotic and nonmitotic fibroblasts, histone H1 is re-
tained in the cell pellets; in contrast, the vast majority of
HMG1 is released into the medium. Moreover, HMG-I(Y),
a different high mobility group protein which is a component
of isolated condensed chromosomes (Saito and Laemmli,
1994) was retained after permeabilization in both mitotic
and nonmitotic cells.
These results demonstrate that HMG1 is released as
easily from condensed and noncondensed chromosomes.
Since HMG1 is apparently excluded from mitotic chromo-
somes, its association to interphase chromatin is also very
weak.
Discussion
By using several purified antibodies, we have clearly es-
tablished that HMG1 protein is exclusively located in the
nucleus in several cell lines. The discrepancy with previous
results (for review see Einck and Bustin, 1985) may in part
be related to the quality of the antibodies used and to po-
tential cross reaction to HMG1-like molecules. The distri-
bution of epitope-tagged HMG1, however, confirms that
HMG1 normally resides in the nucleus.
Confocal microscopy shows that HMG1 is fairly uni-
formly distributed in the interphase nucleus, with the nota-
ble exclusion from nucleoli. We did not see any specific as-
sociation with (or exclusion from) heterochromatin or
speckles containing transcription and splicing factors. This
distribution is compatible with a function of HMG1 as a
bulk component of chromatin like histone H1, as origi-
nally postulated (for review see van Holde, 1988). How-
ever, the properties of HMG1 and histone H1 differ in two
important respects: displacement from condensed chro-
mosomes and association to chromatin in permeabilized
nuclei.
HMG1 is not a component of metaphase chromosomes
and diffuses to the cytoplasm when the nuclear membrane
is broken down at prometaphase (Fig. 4). By partially sol-
ubilizing the membranes of metaphase cells, we can show
that condensed chromatin is almost completely devoid of
HMG1 but retains core and linker histones as well as the
high mobility group protein HMG-I(Y) (Figs. 7 and 8).
There is no loss or degradation of HMG1 at metaphase
(Fig. 8, compare lanes 1 and 3), and we are unable to de-
tect any M phase–specific posttranslational modification of
the protein (results not shown). Thus, HMG1 is displaced
from condensed chromosomes like most transcription fac-
tors (Martinez-Balbás et al., 1995), in stark contrast to the
Drosophila HMG1-like protein HMG-D during embryo-
genesis (Ner and Travers, 1994).
We have also shown a quantitatively minor association
of HMG1 to chromatin even during interphase. HMG1 is
almost completely absent from nucleosomal particles ob-
tained by partial digestion of whole nuclei (from Fig. 6 we
estimate that a maximum of 2% of the total amount of
HMG1 is associated with polynucleosomes) and readily leaks
out from detergent-permeabilized interphase cells (Figs. 7
and 8), again in contrast to histone H1 and HMG-I(Y).
However, in vitro mammalian HMG1 forms stable com-
plexes with reconstituted nucleosomes (Fig. 3), as previ-
ously shown for Xenopus HMG1 (Nightingale et al., 1996).
This paradox may be only apparent, however. Ura et al.
(1996) showed that Xenopus HMG1 and histone H1 asso-
ciate to nucleosomal particles in a way that is qualitatively
similar but quantitatively different. Both histone H1 and
HMG1 bind to linker DNA, have 1:1 stoichiometry to core
nucleosomes, protect chromatosomes from micrococcal
nuclease digestion, restrict nucleosome mobility, and re-
press transcription. In short, there is strong evidence that
HMG1 and histone H1 compete for the very same sites in
chromatin. However, the relative affinity for these sites is
almost 20 times higher for histone H1 than for HMG1
(Ura et al., 1996). Taking into account that in differenti-
ated mammalian cells the molar concentration of histone
H1 is at least 10 times higher than that of HMG1 (Einck
and Bustin, 1985), one can expect that histone H1 will ef-
fectively outcompete HMG1 from linker DNA, as we have
shown experimentally.
The outcome of the competition between HMG1-like
molecules and histone H1 may be completely reversed
during early embryogenesis: Xenopus and Drosophila em-
bryos have a large stock of maternally inherited HMG1
and HMG-D, respectively (Kleinschmidt et al., 1983; Dim-
itrov et al., 1993, 1994; Ner and Travers, 1994). Moreover,
histone H1 is absent until after the midblastula transition,
which occurs late in both organisms. Thus, HMG1 and
HMG-D may “play linker histone” until H1 is expressed
and takes over. Whether the same applies to mammalian
embryogenesis is not obvious, since midblastula transition
occurs at the four-cell stage in the mouse (Hogan et al.,
1986), and the concentrations of HMG1 and H1 before
that stage have not been measured precisely yet.
In conclusion, our results suggest that histone H1 and
HMG1 do not play equivalent roles in differentiated mam-
malian cells like fibroblasts but do not yet exclude that
HMG1 might vicariate H1 during mammalian early em-
bryogenesis. The phenomenon of mitotic displacement
and the weak association to chromatin disprove a struc-
tural role for HMG1 in the packaging of bulk DNA in dif-
ferentiated cells but are fully compatible with the stable
association of HMG1 with a very minor population of nu-
cleosomes or the involvement of HMG1 in transient inter-
Figure 8. HMG1 leaks out in
a similar way from both in-
terphasic and mitotic perme-
abilized cells. NIH 3T3 fibro-
blasts were exposed overnight
to nocodazole, an inhibitor of
microtubule polymerization.
Cells that had entered M
phase could not proceed fur-
ther and were detached from
their plastic substrate by
manual shaking (metaphase
cells). Cells that remained
adherent to the substrate af-
ter shaking (interphase cells)
were detached by treatment with trypsin. The two cell popula-
tions were checked for the presence of condensed chromosomes
(95% for metaphase cells; 2% for interphase cells). The cell sus-
pensions were then exposed to 0.1% NP-40 and immediately cen-
trifuged. Supernatants (lanes 1 and 3, S) and cell pellets (lanes 2
and 4, P) were analyzed by Western blotting with antibodies
against HMG1, histone H1, and protein HMG-I(Y).The Journal of Cell Biology, Volume 137, 1997 26
actions with chromatin or individual nucleosomes. HMG1
and 2 can ply and mould DNA and have been shown to co-
operate with the progesterone receptor, Oct proteins, and
HOX gene products in the control of gene expression
(Oñate et al., 1994; Zwilling et al., 1995; Zappavigna et al.,
1996). We hold the view that the abundance of HMG1 and
2 simply reflects their versatility and usefulness in the con-
struction of a multitude of transient and specialized nucle-
oprotein complexes, in defiance of the structural rigidity of
naked DNA.
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